By Hershel Toomim (about the author) Page 3 of 4 page(s)
futurehealth.org
These results fall naturally into two groups:
1) Studies done by the most accomplished providers gained 0.52 TOVA points per session.
2) Studies done with home, school, or average providers cluster about 0.37 TOVA points per session.
That
the per session scores cluster so closely about either 0.52 or 0.37 is
completely unexpected since the number of reported sessions ranged from
20 to 40 and each provider had a favorite set of parameters and
procedures. It is also unexpected that the initial scores that measure
the degree of dysfunction of the patients had no effect on the gains
per session.
One would expect gains to decrease as the number of
sessions increased and the patients approached normal. That this didn't
happen suggests 40 EEG sessions is insuffi cient for the average
patient even with the most accomplished providers.
It is noteworthy that the HEG study falls into a completely new
treatment effi ciency category. HEG gains are more than double the
gains shown for other techniques.
From these studies we can see that the procedures are very tolerant of provider skills. One can hardly go wrong.
The major variable is the cost to the patient. There are no known side
effects for HEG treatments. Can't remember? Can't focus? Misplace
things? Slow learning? Always tired? Turned around?
These are some common physical brain problems.
Healthy brains have adequate blood flow. Problem brains have insufficient blood flow to limited brain areas.
Several brain areas are involved in whatever you do. Finding the
affected areas is key. A non-invasive directed brain exercise is
indicated.
Please refer to Toomim's Questionnaire, designed to point out the brain areas needing exercise to counter hypoperfusion.

Ten/Twenty International
Brain Position Naming System
References
Elwell, C., Hebden, J., Biomedical Research Group: Near-infrared Spectroscopy
Kaiser, DA., Efficacy of Neurofeedback on adults with attentional defi cit and related disorders. EEG Spectrum Inc. December 1997
Drevets WC, Price JL, Simpson JR, Todd RD, Reich T, Vannier M, Raichle ME., Subgenual prefrontal cortex abnormalities in mood disorders, Nature 1997 April 24;386(6627):824-7
Heuser
G, Mena L, Alamos F., NeuroSPECT fi ndings in patients exposed to
neurotoxic chemicals. Toxicol Ind Health 1994 Jul.;10(4-5):561-571
Andreason
NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL,
Hichiwa RD. Hypofrontality in schizophrenia: dysfunctional circuits in neuroleptic-naive patients. Lancet 1997 Jun. 14;349(9067):1730-34
1 | 2 | 3 | 4
Lifetime in innovative research resulting in many honors, patents, and pioneering development of biofeedback computer based instrumentation including Biocomp 2010 followed by invention of hemoencephalography (HEG)
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.